🟢 Intravenous Infusions is trading 8.33% up today amid elevated activity without a confirmed catalyst

Intravenous Infusions is trading at GHS 0.65, gaining +8.33% today amid elevated activity with no confirmed catalyst identified.

• No company-specific announcement dated August 24, 2026 was identified.
• The move extends a sharp rebound from GHS 0.40 on August 12, 2026, with gains across consecutive sessions.
• Recent commentary cites approximately 2.25 million shares traded during the weekly advance; the August 4, 2026 profitability update is stale and cannot clearly explain today’s movement.